Paclitaxel and concurrent radiation for gastric cancer
- 1 March 2000
- journal article
- clinical trial
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 46 (4) , 889-894
- https://doi.org/10.1016/s0360-3016(99)00436-8
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Multiinstitutional phase II trial of paclitaxel, carboplatin, and concurrent radiation therapy for locally advanced non-small-cell lung cancer.Journal of Clinical Oncology, 1998
- Cancer statistics, 1998CA: A Cancer Journal for Clinicians, 1998
- Effect of radiation and paclitaxel of p53 expression in murine tumors sensitive or resistant to apoptosis inductionInternational Journal of Radiation Oncology*Biology*Physics, 1997
- Cytotoxicity and cell-cycle effects of paclitaxel when used as a single agent and in combination with ionizing radiationInternational Journal of Radiation Oncology*Biology*Physics, 1997
- Phase I trial of outpatient weekly paclitaxel and concurrent radiation therapy for advanced non-small-cell lung cancer.Journal of Clinical Oncology, 1994
- Taxol in combination with acute and low dose rate irradiationRadiotherapy and Oncology, 1994
- Activity of Taxol in Patients With Squamous Cell Carcinoma and Adenocarcinoma of the EsophagusJNCI Journal of the National Cancer Institute, 1994
- In Vitro Studies of Taxol as a Radiation Sensitizer in Human Tumor CellsJNCI Journal of the National Cancer Institute, 1994
- Investigation of taxol as a potential radiation sensitizerCancer, 1993
- Adenocarcinoma of the stomach: Areas of failure in a re-operation series (second or symptomatic look) clinicopathologic correlation and implications for adjuvant therapyInternational Journal of Radiation Oncology*Biology*Physics, 1982